Population pharmacokinetic analysis of tacrolimus in Chinese myasthenia gravis patients.
Ontology highlight
ABSTRACT: The importance of tacrolimus in the treatment of myasthenia gravis (MG) as a substitute for corticosteroid-dependent immunosuppressive therapy is increasing. Thus far, however, no population pharmacokinetic (PopPK) analysis of tacrolimus in treating MG patients has been published. This article aimed to construct a PopPK model of tacrolimus for Chinese MG patients with the goal of improving its performance in MG treatment. A total of 253 trough concentration records were obtained from 83 Chinese MG patients. The effects of demographics, lifestyle and health status, biochemical test data, disease progression and treatment-related information (including co-administered medications) as covariates on the various parameters were investigated. The covariate selection was based on biological plaus
SUBMITTER: Chen YS
PROVIDER: S-EPMC5547552 | biostudies-literature | 2017 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA